FDA to Zeltia: NO - An FDA advisory committee has handed Spain's Zeltia a crushing blow, deciding against a combination therapy that includes its lead cancer drug Yondelis (trabectedin) by a vote of …
Today’s Top Pharma News 71309
Finally - FDA approves DSI/Lilly blood thinner Effient. Narrow indication with warnings, however - The approval makes Lilly's Effient the first real competition to the blood thinner Plavix, the …
Today’s Top Three in Pharma 020409
Finally! New anti-clotting drug prasugrel (Effient) is given a thumbs up by advisory committee! Great news for Daiichi Sankyo and Eli Lilly. King Pharmaceuticals the latest to announce major layoffs …
Pharma News this week (and last)
Roche's MabThera can help extend CLL patients' lives. Meanwhile, surprisingly good results for AZ's lung cancer drug Iressa. But, disappointment for an experimental lung cancer drug being developed by …
Pharma News 10_20
Novartis to cut a bunch more (sales) jobs; does another management shuffle - As reorganizations go, this one reaches most parts of the company. First, the drugmaker is cutting 550 sales reps, although …